Therefore, the reduced ADAMTS13 activity associated with the recipient C/C genotype may result in increased vWF, possibly promoting the progression of hematologic malignancies due to a decreased function of vascular endothelial cells, although these considerations remain speculation because the blood vWF levels were not measured in the current study. Here, VWF is linked to hematologic disorder.